{"product_id":"ghrh-t44","title":"GHRH-T44","description":"\u003ch2\u003eGHRH-T44 Research Peptide\u003c\/h2\u003e\u003cp\u003eGHRH-T44 is offered as a laboratory research peptide. Confirm the full product identity and presentation for your project; this listing should not be treated as interchangeable with the shorter GHRH(1-29) material commonly called sermorelin.\u003c\/p\u003e\u003ch3\u003eProduct information\u003c\/h3\u003e\u003cp\u003eSelect from the presentations shown on this page. For a specific batch or analytical requirement, contact \u003ca href=\"mailto:support@bulkpeptides.org\"\u003esupport@bulkpeptides.org\u003c\/a\u003e for available product documentation before ordering.\u003c\/p\u003e\u003cp\u003e\u003ca href=\"\/pages\/ghrh-t44-research-guide\"\u003eRead the GHRH-T44 research guide\u003c\/a\u003e\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e Not for human or veterinary use, diagnosis, treatment, or clinical application.\u003c\/p\u003e\u003csection class=\"product-research-information\"\u003e\u003ch2\u003eProduct research information\u003c\/h2\u003e\n\u003cp\u003eGHRH-T44 is a synthetic growth hormone-releasing hormone analog with the molecular formula C₂₂₁H₃₆₆N₇₂O₆₇S. It is structurally based on the full 44-amino-acid human growth hormone-releasing factor sequence and includes an N-terminal trans-3-hexenoyl modification. This modification has been studied for its ability to improve peptide stability by reducing susceptibility to enzymatic degradation, including degradation associated with dipeptidyl peptidase-IV (DPP-IV).\u003c\/p\u003e\n\u003cp\u003eResearch involving GHRH-T44 focuses on its interaction with growth hormone-releasing hormone receptors located on somatotroph cells of the anterior pituitary. In laboratory models, receptor binding has been associated with stimulation of endogenous growth hormone signaling and downstream evaluation of insulin-like growth factor 1 (IGF-1) response. Because this compound acts through the GHRH receptor pathway, it is commonly studied in relation to pulsatile growth hormone release patterns rather than direct growth hormone replacement.\u003c\/p\u003e\n\u003cp\u003eA major area of investigation involves metabolic signaling, lipid metabolism, and body-composition-related research models. Studies have evaluated GHRH analogs for their effects on visceral adipose tissue, hepatic lipid markers, triglyceride regulation, and broader metabolic dysregulation pathways. These research applications make GHRH-T44 useful for studying the relationship between growth hormone axis modulation, lipolysis, and adipose tissue distribution in controlled non-clinical settings.\u003c\/p\u003e\n\n\u003cp\u003eReferences\u003c\/p\u003e\n\u003cp\u003eFerdinandi, E. S., et al. (2007). “Preclinical pharmacokinetics and metabolism of TH9507, a growth hormone-releasing factor analog, in mice, rats, dogs, and monkeys.” Journal of Endocrinology, 195(1), 1-14.\u003c\/p\u003e\n\u003cp\u003eMakimura, H., et al. (2013). “Reduced growth hormone secretion is associated with increased visceral adiposity in healthy older adults.” The Journal of Clinical Endocrinology \u0026amp; Metabolism, 98(5), 2090-2097.\u003c\/p\u003e\n\u003cp\u003eStanley, T. L., et al. (2011). “Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.” The Journal of Clinical Endocrinology \u0026amp; Metabolism, 96(1), 150-158.\u003c\/p\u003e\u003c\/section\u003e","brand":"Bulk Peptides","offers":[{"title":"10 MG","offer_id":51303543079079,"sku":"GHRH-T44-10MG","price":79.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0770\/0384\/9895\/files\/ghrh-t44.png?v=1788658194","url":"https:\/\/bulkpeptides.org\/products\/ghrh-t44","provider":"Bulk Peptides","version":"1.0","type":"link"}